Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kensuke Takagi

Showing results (251-260 of 253) with videos related to

Pageof 26
Sort By:
You have reached the last page of results.This site can display upto 253 results.
Atherosclerosis|August 16, 2025
Apolipoprotein CIII in statin-treated type 2 diabetic patients: Its implications for plaque progression and instability: The pre-specified analysis from the OPTIMAL randomized controlled trialSatoshi Kitahara, Yu Kataoka, Stephen J Nicholls, et al.
JAMA|June 26, 2019
Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI: The STOPDAPT-2 Randomized Clinical TrialHirotoshi Watanabe, Takenori Domei, Takeshi Morimoto, et al.
Cardiovascular Intervention and Therapeutics|February 23, 2020
Details on the effect of very short dual antiplatelet therapy after drug-eluting stent implantation in patients with high bleeding risk: insight from the STOPDAPT-2 trialHirotoshi Watanabe, Takenori Domei, Takeshi Morimoto, et al.
Pageof 26

Showing results (251-260 of 253) with videos related to

Sort By:
Pageof 26
You have reached the last page of results.This site can display upto 253 results.
Atherosclerosis|August 16, 2025
Apolipoprotein CIII in statin-treated type 2 diabetic patients: Its implications for plaque progression and instability: The pre-specified analysis from the OPTIMAL randomized controlled trialSatoshi Kitahara, Yu Kataoka, Stephen J Nicholls, et al.
JAMA|June 26, 2019
Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI: The STOPDAPT-2 Randomized Clinical TrialHirotoshi Watanabe, Takenori Domei, Takeshi Morimoto, et al.
Cardiovascular Intervention and Therapeutics|February 23, 2020
Details on the effect of very short dual antiplatelet therapy after drug-eluting stent implantation in patients with high bleeding risk: insight from the STOPDAPT-2 trialHirotoshi Watanabe, Takenori Domei, Takeshi Morimoto, et al.
Pageof 26